HVC
GYRE icon

Healthcare Value Capital’s Gyre Therapeutics GYRE Stock Holding History

Healthcare Value Capital’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-257
Closed -$1.08M – 39
2013
Q3 		$1.08M Buy
+257
New +$1.03M 0.94% 34

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Healthcare Value Capital's GYRE Position: Q4 2013 in Review

Healthcare Value Capital sold out of Gyre Therapeutics (GYRE) in Q4 2013, closing a stake of 257 shares — an estimated $1.08M sold.

Healthcare Value Capital first reported a position in GYRE in Q3 2013 and held it in 1 quarter. The position peaked at $1.08M in Q3 2013. 74 funds tracked by Wall St. Rank hold GYRE as of Q4 2013.

  • Healthcare Value Capital reported no remaining Gyre Therapeutics position as of Q4 2013 after selling out during the quarter.
  • Healthcare Value Capital sold 257 Gyre Therapeutics shares in Q4 2013, an estimated $1.08M.
  • Healthcare Value Capital first reported a position in Gyre Therapeutics in Q3 2013 and held it in 1 quarter.
  • Healthcare Value Capital's Gyre Therapeutics position peaked at $1.08M in Q3 2013.
  • 74 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2013.

Based on Healthcare Value Capital's 13F filing for Q4 2013, filed 13 Feb 2014.